Dan Strange

Head of Cell Therapy Technology • TTP

Dr Dan Strange is a biomedical engineer at TTP, an independent technology company that invents, designs and develops automation, tools and technologies for cell therapy manufacturing, working in close partnership with clients from across this industry. Dan has as worked across the ‘arm to arm spectrum’, on devices for tissue collection, cell selection, expansion and delivery, and with leading pharmaceutical companies to develop and commercialise devices for complex medicines used by hundreds of thousands of patients per year with high reliability rates. He is passionate about designing technology for a future where cell therapies have similar reach.

Also Speaking

Matthew Hewitt

Senior Director, Scientific Services, Cell and Gene Therapy • Charles River

Timothy Schroeder

Chairman, Chief Executive Officer and Founder • CTI

Amritha Jaishankar

Executive Director • Maryland Stem Cell Research Fund

Event Info


Fun Run